Two phospholipids fused into one — the signature lipid of the inner mitochondrial membrane, where it anchors the respiratory chain, and the molecule whose failed remodeling causes Barth syndrome cardiomyopathy. It was first isolated from beef heart, the tissue that gave it its name.
Lipid Class
Diphosphatidylglycerol, anionic phospholipid
Core Composition
Two phosphatidyl residues joined by a central glycerol — four acyl chains
Primary Location
Mitochondrion, inner membrane — about 20 percent of its lipid
Four linoleate chains (18:2) in most animal tissues
Associated Conditions
Barth syndrome; anti-cardiolipin antibodies
Structure & Classification
Two phosphatidic acid moieties joined through a central glycerol give cardiolipin four alkyl chains and two negative charges; its headgroup forms a bicyclic resonance structure with pK1 near 3 and pK2 above 7.5.
Most animal tissues load it with four linoleoyl (18:2) chains — the configuration inner-membrane proteins favor.
Mary Pangborn isolated it from beef heart in the early 1940s; the name records its cardiac origin.
Maturation then falls to tafazzin, a phospholipid transacylase that rebuilds the acyl chains — transferring linoleate from phosphatidylcholine onto monolysocardiolipin.
Failed remodeling leaves cardiolipin species heterogeneous, monolysocardiolipin elevated and total cardiolipin reduced.
Physiological Role
Respiratory chain scaffold in oxidative phosphorylation: complex IV requires two cardiolipin molecules for full activity, complex III needs it for quaternary structure, and ATP synthase binds four per complex.
Its proton-trapping headgroup is proposed to pool protons locally for the respiratory machinery.
Apoptosis switch: oxidation and externalization of cardiolipin help open the pore that releases cytochrome c, triggering apoptotic caspase cascades and NLRP3 inflammasome activation.
Interactions
A cardiolipin-specific oxygenase generates cardiolipin hydroperoxides, tying its turnover to oxidative stress.
Coupled to cardiac myocyte energetics — heart muscle, the tissue that first revealed it.
Clinical Relevance
Barth syndrome: X-linked mutations or deletions of tafazzin at Xq28 cause dilated cardiomyopathy, skeletal myopathy, growth delay, neutropenia and urinary 3-methylglutaconic acid — first described in 1983.
Mechanistically, deranged cardiolipin slows electron transport, backing up NADH, stalling TCA enzymes and diverting pyruvate to lactate — the lactic acidosis of Barth patients.
Cow-heart cardiolipin is the antigen of the classic Wassermann test for syphilis; anti-cardiolipin antibodies also mark antiphospholipid syndrome with recurrent thrombosis.